A
ADAP
Abingworth’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-250,000
| Closed | -$1.44M | – | 15 |
|
|
2018
Q4 | $1.44M | Hold |
250,000
| – | – | 1.31% | 13 |
|
|
2018
Q3 | $3.39M | Hold |
250,000
| – | – | 2.02% | 8 |
|
|
2018
Q2 | $2.97M | Hold |
250,000
| – | – | 1.69% | 10 |
|
|
2018
Q1 | $2.81M | Hold |
250,000
| – | – | 1.74% | 11 |
|
|
2017
Q4 | $1.67M | Hold |
250,000
| – | – | 1.21% | 14 |
|
|
2017
Q3 | $2.05M | Hold |
250,000
| – | – | 1.42% | 12 |
|
|
2017
Q2 | $1.13M | Hold |
250,000
| – | – | 0.9% | 15 |
|
|
2017
Q1 | $1.38M | Hold |
250,000
| – | – | 1.02% | 14 |
|
|
2016
Q4 | $1M | Hold |
250,000
| – | – | 0.84% | 15 |
|
|
2016
Q3 | $1.76M | Hold |
250,000
| – | – | 1.69% | 14 |
|
|
2016
Q2 | $2.03M | Hold |
250,000
| – | – | 2.13% | 13 |
|
|
2016
Q1 | $2.03M | Hold |
250,000
| – | – | 1.88% | 13 |
|
|
2015
Q4 | $3.01M | Buy |
+250,000
| New | +$3.01M | 1.82% | 11 |
|